AFM and type 2 diabetes mellitus: In a large multicenter population-based study, circulating afamin was associated independently with prevalent and incident type 2 diabetes (OR 1.30 [95% CI 1.23–1.38]; p < 0.001) indicating that afamin can be a promising novel biomarker to identify subjects with a high risk of type 2 diabetes [98].